IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting tregs in adipose tissue and systemic insulin sensitivity

导出原文传递

翻译打印收藏纠错

作者： Fabrizi,M. ^[1] ; Marchetti,V. ^[2] ; Mavilio,M. ^[3] ; Marino,A. ^[4] ; Casagrande,V. ; Cavalera,M. ; Moreno-Navarrete,J.M. ; Mezza,T. ; Sorice,G.P. ; Fiorentino,L. ; Menghini,R. ; Lauro,R. ; Monteleone,G. ; Giaccari,A. ; Real,J.M.F. ; Federici,M.

作者单位： University Department of Diabetes, Endocrinology and Nutrition, University Hospital of Girona Dr ^[1] Division of Endocrinology and Metabolic Diseases, Università Cattolica Del Sacro Cuore, Rome, Italy ^[2] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy, Center for ^[3] Department of Systems Medicine, University of Rome Tor Vergata, Rome, Italy ^[4]

发布时间 2014-09-24

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览0

Diabetes

2014年63卷6期

2086-2096页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting tregs in adipose tissue and systemic insulin sensitivity

Diabetes

相似文献

Diabetes

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

IL-21 is a major negative regulator of IRF4-dependent lipolysis affecting tregs in adipose tissue and systemic insulin sensitivity

Diabetes

相似文献

Diabetes

相关期刊

检索历史清除